Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade. [electronic resource]
Producer: 20180910Description: 3485-3492 p. digitalISSN:- 1791-244X
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Female
- Humans
- Isoflavones -- pharmacology
- MAP Kinase Signaling System -- drug effects
- Ovarian Neoplasms
- Proto-Oncogene Proteins c-raf -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.